104 related articles for article (PubMed ID: 2494714)
1. Boronated compounds for neutron capture therapy.
Alam F; Bapat BV; Soloway AH; Barth RF; Mafune N; Adams DM
Strahlenther Onkol; 1989; 165(2-3):121-3. PubMed ID: 2494714
[No Abstract] [Full Text] [Related]
2. Boronated antibodies for neutron capture therapy.
Abraham R; Müller R; Gabel D
Strahlenther Onkol; 1989; 165(2-3):148-51. PubMed ID: 2494718
[No Abstract] [Full Text] [Related]
3. Conjugation, purification and characterization of boronated monoclonal antibodies for use in neutron capture therapy.
Barth RF; Mafune N; Alam F; Adams DM; Soloway AH; Makroglou GE; Oredipe OA; Blue TE; Steplewski Z
Strahlenther Onkol; 1989; 165(2-3):142-5. PubMed ID: 2494716
[No Abstract] [Full Text] [Related]
4. Boronated monoclonal antibodies for potential neutron capture therapy of malignant melanoma and leukaemia.
Tamat SR; Patwardhan A; Moore DE; Kabral A; Bradstock K; Hersey P; Allen BJ
Strahlenther Onkol; 1989; 165(2-3):145-7. PubMed ID: 2494717
[No Abstract] [Full Text] [Related]
5. Plan for synthesis of biomolecules for neutron capture therapy of cervical carcinoma.
Wongwiechintana C; Choonchartprasert S; Tampitak S; Prachayasittigul S
Strahlenther Onkol; 1989; 165(2-3):125-6. PubMed ID: 2494715
[No Abstract] [Full Text] [Related]
6. Integrated approach in the planning of neutron capture therapy.
Ryabukhin YS
Strahlenther Onkol; 1989; 165(2-3):158-62. PubMed ID: 2494721
[No Abstract] [Full Text] [Related]
7. Boronophenylalanine for neutron capture therapy of melanoma.
Coderre JA; Glass JD; Fairchild RG; Micca P; Kalef-Ezra J
Strahlenther Onkol; 1989; 165(2-3):215-7. PubMed ID: 2494733
[No Abstract] [Full Text] [Related]
8. Biological effects of intermediate-energy neutrons and their relevance to boron neutron capture therapy.
Mill AJ
Strahlenther Onkol; 1989; 165(2-3):193-6. PubMed ID: 2494726
[No Abstract] [Full Text] [Related]
9. Fast neutrons from the Essen cyclotron can be used successfully for neutron capture experiments in vitro.
Ziegler W; Sauerwein W; Streffer C
Strahlenther Onkol; 1989; 165(2-3):210-2. PubMed ID: 2494731
[No Abstract] [Full Text] [Related]
10. Biological efficacy of a boronated porphyrin as measured in cell culture.
Laster BH; Kahl SB; Kalef-Ezra J; Popenoe EA; Fairchild RG
Strahlenther Onkol; 1989; 165(2-3):203-5. PubMed ID: 2494728
[No Abstract] [Full Text] [Related]
11. The incorporation of boronated substances into melanin in vitro--an experimental model for melanotic melanoma.
Roberto A; Larsson BS
Strahlenther Onkol; 1989; 165(2-3):165-7. PubMed ID: 2494722
[No Abstract] [Full Text] [Related]
12. Method of in situ dosimetry in boron neutron capture therapy.
Blue J; Roberts W; Blue T; Wang C
Strahlenther Onkol; 1989; 165(2-3):109-12. PubMed ID: 2494710
[No Abstract] [Full Text] [Related]
13. Fractionation and other clinical considerations in boron neutron capture therapy.
Durrant KR; Hopewell JW
Strahlenther Onkol; 1989; 165(2-3):231-3. PubMed ID: 2494739
[No Abstract] [Full Text] [Related]
14. Optimization of fast neutron spectra available for neutron capture therapy.
Pfister G; Hehn G; el-Husseini F
Strahlenther Onkol; 1989; 165(2-3):107-9. PubMed ID: 2494709
[No Abstract] [Full Text] [Related]
15. A design study of an accelerator-based epithermal neutron source for boron neutron capture therapy.
Wang CK; Blue TE; Gahbauer RA
Strahlenther Onkol; 1989; 165(2-3):75-8. PubMed ID: 2494748
[No Abstract] [Full Text] [Related]
16. Reactor moderated intermediate energy neutron beams for neutron capture therapy.
Less TJ; Brugger RM
Strahlenther Onkol; 1989; 165(2-3):87-90. PubMed ID: 2494752
[No Abstract] [Full Text] [Related]
17. Neutron capture therapy with gadolinium-157.
Allen BJ; McGregor BJ; Martin RF
Strahlenther Onkol; 1989; 165(2-3):156-8. PubMed ID: 2494720
[No Abstract] [Full Text] [Related]
18. Analytical modeling for neutron capture therapy.
Wheeler FJ; Griebenow ML; Wessol DE; Nigg DW
Strahlenther Onkol; 1989; 165(2-3):186-8. PubMed ID: 2494724
[No Abstract] [Full Text] [Related]
19. RBE of thermal neutron capture therapy using 10B1-para-boronophenylalanine for human and B-16 melanoma cells.
Ichihashi M; Sasase A; Hiramoto T; Mishima Y; Fukuda H; Kobayashi T
Strahlenther Onkol; 1989; 165(2-3):198-201. PubMed ID: 2494727
[No Abstract] [Full Text] [Related]
20. Neutron beams for neutron capture therapy at the MIT Research Reactor.
Harling OK; Clement SD; Choi JR; Bernard JA; Zamenhof RG
Strahlenther Onkol; 1989; 165(2-3):90-2. PubMed ID: 2494753
[No Abstract] [Full Text] [Related]
[Next] [New Search]
